Á¦23ȸ ´ëÇÑ°³¿ø³»°úÀÇ»çȸ Á¤±âÃÑȸ ¹× Ãß°èÇмú´ëȸ : 2020-10-18±³À°ÀÏÀÚ : 2020-10-18
±³À°Àå¼Ò : ¼Ò°øµ¿ ·Ôµ¥È£ÅÚ 2Ãþ Å©¸®½ºÅ»º¼·ë
±³À°ÁÖÁ¦ :
Á¦23ȸ ´ëÇÑ°³¿ø³»°úÀÇ»çȸ Á¤±âÃÑȸ ¹× Ãß°èÇмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇÑ°³¿øÀÇÇùÀÇȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ°³¿ø³»°úÀÇ»çȸ
´ã´çÀÚ : ÃÖ¿ì³ç
¿¬¶ôó : 02-582-9265
À̸ÞÀÏ :
kpa@physician.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 5Á¡ (ÀÏ¹Ý 3Á¡ / Çʼö 2Á¡)
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í ȸ¿ø ¹«·á, ȸºñ¹Ì³³È¸¿ø 3¸¸¿ø, ºñȸ¿ø 6¸¸¿ø ÇöÀåµî·Ï ¾øÀ½
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ë 09:00~09:30 ÀÏÂ÷ÀÇ·á±â°ü¿¡¼ Äڷγª19 ½Ã´ë¿¡ È£Èí±â ȯÀÚ Áø·á ±èŹ(¼øõÇâÀÇ´ë °¨¿°³»°ú)
±³À°½Ã°£ 10¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ë 09:30~10:00 ¹Ì·¡ÀÇ·á¿Í °ø°ø¼º ±è¼Ò¿¬(¿¬¼¼ÀÇ´ë ÀÇ·á¹ýÀ±¸®Çаú)
ÈÞ½Ä 10¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ë 10:00~11:10 °³È¸»ç ¹× Ãà»ç ()
±³À°½Ã°£ 10¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ë 11:10~11:30 Á¤¸ÆÁúȯ:ÇÏÁöºÎÁ¾¿¡ ´ëÇÑ ÀÌÇØ¿Í ¾à¹«맃·á ¿ä¹ý À¯º´¿í(¼øõÇâÀÇ´ë °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 10¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ë 11:30~11:50 Strategies to overcome residual risk during statin era È«Àº°æ(ÇѸ²ÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 10¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ë 11:50~12:10 ÀÎÇ÷翣ÀÚ Ä¡·áÀÇ »õ·Î¿î Æз¯´ÙÀÓ ±èÅÂÇü(¼øõÇâÀÇ´ë °¨¿°³»°ú)
±³À°½Ã°£ 10¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ë 12:10~12:30 ´Ù¾çÇÑ µÎÅëÀÇ °¨º°Áø´Ü ¹× Ä¡·á ¹®Èñ¼ö(¼º±Õ°üÀÇ´ë ½Å°æ°ú)
½Ä»ç 10¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ë 12:30~13:30 ½Ä»ç ()
±³À°½Ã°£ 10¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ë 13:30~14:30 Áø·áÇöÀå¿¡¼ ÀÇ·áÀ±¸®¶õ ¹«¾ùÀΰ¡? ¾È´ö¼±(ÀÇÇù ÀÇ·áÁ¤Ã¥¿¬±¸¼Ò)
ÈÞ½Ä 10¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ë 14:30~14:45 ÈÞ½Ä ()
±³À°½Ã°£ 10¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ë 14:45~15:10 ÀÌ·±°Ë»çµµ º¸ÇèÀÌ µÈ´Ù±¸¿ä? À̹ÌÁ¤(Â÷ÀÇ°ú´ëÇÐ ½ÅÀå³»°ú)
±³À°½Ã°£ 10¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ë 15:10~15:35 Ç︮ÄÚ¹ÚÅÍ °Ë»ç ¹× Á¦±Õ º¸Çè±âÁØ 2020 ÀÌâÇö(¼¿ïÇູ³»°ú)
±³À°½Ã°£ 10¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ë 15:35~16:00 °©»ó¼± ±â´ÉÀúÇÏÁõ Ä¡·áÀÇ ÃÖ½ÅÁö°ß ±Ç¼øÈ£(»þ¿ì½ºÄ³·Ñ¶óÀ̳ª ÀÇ´ë)
±³À°½Ã°£ 10¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ë 16:00~16:25 Omega-3 fatty acid recommendation for therapy & prevention ÀÌÀçÇõ(¸íÁöº´¿ø ³»ºÐºñ³»°ú)